Ines Martins, PhD,  —

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.

Articles by Ines Martins

Meso Scale Discovery Develops Platform to Detect Autoimmune Disease Biomarkers

Meso Scale Discovery (MSD) has developed a biochemical testing platform that can detect biomarkers involved in autoimmune diseases like systemic lupus erythematosus (SLE). The V-PLEX platform can detect the biomarkers IL-17A, IL-21, IL-22, IL-23, IL-27, and MIP-3α in human cell culture supernatants, or liquids, in the blood components plasma and serum,…

Neovacs, BioSense Ink Accord to Develop Lupus Vaccine in China

Neovacs and BioSense Global will jointly develop an interferon alpha (IFNα) vaccine to treat lupus and dermatomyositis in China. News of the commercial licensing agreement, worth up to €65 million, comes just days after Chinese authorities issued a patent for Neovacs’ IFNα vaccine (IFNα Kinoid) for diseases characterized by over-expression of the cytokine…

Exagen’s Lupus and Rheumatoid Arthritis Dose Tests Earn Endorsement

A test that Exagen Diagnostics developed to help doctors control levels of a lupus therapy in patients’ blood has been endorsed by a company that supports arthritis and rheumatology practitioners around the United States, Exagen announced. American Arthritis and Rheumatology Associates (AARA) powered by Bendcare also endorsed an Exagen blood test for rheumatoid arthritis.

‘World’s Greatest Moms’ are not Defined by Lupus

Having lupus has meant a lot of things to my family. It’s meant weekly doctor visits, sleepless nights, missed choir and band performances, and too many cancelled vacations to count. When I wasn’t sick from lupus, I was working just to maintain my health insurance. Living with…

Voclosporin Has Potential to Treat LN Regardless of Ethnicity, Study in Japan Reports

Voclosporin, a drug being developed to treat lupus nephritis (LN), appears to be safe for patients regardless of ethnicity, according to a Phase 1 clinical trial conducted in healthy Japanese, Aurinia Pharmaceuticals reports. The treatment also has a good pharmacokinetic (PK) and pharmacodynamic (PD) profile. PK refers to the body’s reaction to a drug…

AARDA Launches Patient Registry for Lupus, Other Autoimmune Diseases

The world’s first registry for patients with lupus and other autoimmune diseases has gone online, just in time for National Autoimmune Disease Awareness Month in March. The Autoimmune Research Network (ARNet), launched by the Michigan-based American Autoimmune Related Diseases Association (AARDA), is a research network that lets scientists obtain data on patients…

China Grants Neovacs a Patent for IFNα Kinoid Treatment for Lupus

China has issued a patent for Neovacs’ interferon alpha (IFNα) vaccine for diseases characterized by  over-expression of the cytokine IFNα, including lupus, dermatomyositis and type 1 diabetes. The patent, together with others Neovacs has obtained, give the company global protection for the vaccine until at least 2032. Neovacs’ technology targets…

Using Lupus and Arthritis as Weather-Forecasting Superpowers

Even before my lupus diagnosis, my body has had amazing accuracy when forecasting the weather. For someone with arthritis, this becomes an unwanted superpower of sorts. Because when the rain hits, so  does the stiffness and pain in my joints. While painkillers can mask the excruciating painful limitations,…